< 1 minute read
Sep. 18, 2021

CG428: A CRBN-Based TRK Kinase Fusion Protein Degrader

CG428

CRBN-based TRK kinase fusion prot. degrader degrad. of mult. TRK fusions (e.g. TPM3-TRKA) from functionalization of lit. TRK inhibitor J. Med. Chem., Oct. 15, 2020 Cullgen Inc., San Diego, CA / Shanghai, CN

drughunter.com
Drug Hunter Team

CG428 (Cullgen CRBN-based TRK kinase fusion protein degrader)

Loading...

twitterlinkedinemail

Other molecules you may be interested in